InsiderClue
Stocks · Health care · Pharmaceutical Preparations

MapLight Therapeutics, Inc.

MPLT Clue Score44
United States Fiscal year ends December CIK 0001770069
8.83
-3.50%
Close, 9 Oct 2026 · USD
Alert on the numbers Alert on insider trades

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
8.83 on 9 Oct 2026
40 24 9 Oct 2025 Apr 2026 Oct 2026 27 Oct 2025 $18.34 28 Oct 2025 $16.75 29 Oct 2025 $16.55 30 Oct 2025 $18.37 31 Oct 2025 $16.92 3 Nov 2025 $16.91 4 Nov 2025 $16.24 5 Nov 2025 $16.00 6 Nov 2025 $16.14 7 Nov 2025 $15.61 10 Nov 2025 $15.39 11 Nov 2025 $15.07 12 Nov 2025 $14.46 13 Nov 2025 $14.28 14 Nov 2025 $14.09 17 Nov 2025 $13.69 18 Nov 2025 $14.87 19 Nov 2025 $14.60 20 Nov 2025 $13.29 21 Nov 2025 $13.99 24 Nov 2025 $13.00 25 Nov 2025 $12.81 26 Nov 2025 $12.99 28 Nov 2025 $13.63 1 Dec 2025 $13.59 2 Dec 2025 $12.89 3 Dec 2025 $16.92 4 Dec 2025 $18.34 5 Dec 2025 $18.49 8 Dec 2025 $18.45 9 Dec 2025 $18.85 10 Dec 2025 $20.41 11 Dec 2025 $20.10 12 Dec 2025 $20.70 15 Dec 2025 $21.08 16 Dec 2025 $20.35 17 Dec 2025 $19.64 18 Dec 2025 $19.94 19 Dec 2025 $20.55 22 Dec 2025 $19.18 23 Dec 2025 $17.86 24 Dec 2025 $18.12 26 Dec 2025 $18.01 29 Dec 2025 $17.73 30 Dec 2025 $17.93 31 Dec 2025 $17.57 2 Jan 2026 $16.77 5 Jan 2026 $17.22 6 Jan 2026 $17.01 7 Jan 2026 $16.06 8 Jan 2026 $17.19 9 Jan 2026 $18.02 12 Jan 2026 $19.07 13 Jan 2026 $17.64 14 Jan 2026 $18.76 15 Jan 2026 $18.48 16 Jan 2026 $17.00 20 Jan 2026 $17.03 21 Jan 2026 $16.95 22 Jan 2026 $18.58 23 Jan 2026 $17.98 26 Jan 2026 $17.98 27 Jan 2026 $19.15 28 Jan 2026 $18.86 29 Jan 2026 $18.58 30 Jan 2026 $17.69 2 Feb 2026 $17.93 3 Feb 2026 $17.11 4 Feb 2026 $16.80 5 Feb 2026 $15.70 6 Feb 2026 $16.98 9 Feb 2026 $17.57 10 Feb 2026 $17.89 11 Feb 2026 $17.77 12 Feb 2026 $17.22 13 Feb 2026 $17.22 17 Feb 2026 $17.25 18 Feb 2026 $17.31 19 Feb 2026 $17.92 20 Feb 2026 $17.88 23 Feb 2026 $18.30 24 Feb 2026 $18.02 25 Feb 2026 $17.63 26 Feb 2026 $17.42 27 Feb 2026 $17.27 2 Mar 2026 $17.60 3 Mar 2026 $18.01 4 Mar 2026 $18.03 5 Mar 2026 $17.96 6 Mar 2026 $18.51 9 Mar 2026 $19.79 10 Mar 2026 $18.97 11 Mar 2026 $18.98 12 Mar 2026 $19.14 13 Mar 2026 $19.07 16 Mar 2026 $18.89 17 Mar 2026 $17.87 18 Mar 2026 $17.02 19 Mar 2026 $17.49 20 Mar 2026 $17.56 23 Mar 2026 $17.08 24 Mar 2026 $16.98 25 Mar 2026 $18.14 26 Mar 2026 $19.23 27 Mar 2026 $18.55 30 Mar 2026 $18.71 31 Mar 2026 $20.33 1 Apr 2026 $20.83 2 Apr 2026 $21.17 6 Apr 2026 $22.61 7 Apr 2026 $24.14 8 Apr 2026 $24.24 9 Apr 2026 $29.41 10 Apr 2026 $26.73 13 Apr 2026 $26.31 14 Apr 2026 $27.02 15 Apr 2026 $26.90 16 Apr 2026 $28.51 17 Apr 2026 $30.05 20 Apr 2026 $28.34 21 Apr 2026 $27.62 22 Apr 2026 $32.13 23 Apr 2026 $29.11 24 Apr 2026 $29.76 27 Apr 2026 $30.64 28 Apr 2026 $30.31 29 Apr 2026 $30.29 30 Apr 2026 $31.87 1 May 2026 $30.70 4 May 2026 $28.61 5 May 2026 $27.92 6 May 2026 $29.04 7 May 2026 $29.20 8 May 2026 $27.40 11 May 2026 $30.09 12 May 2026 $30.30 13 May 2026 $30.67 14 May 2026 $29.29 15 May 2026 $28.73 18 May 2026 $26.50 19 May 2026 $27.08 20 May 2026 $27.81 21 May 2026 $29.28 22 May 2026 $28.75 26 May 2026 $29.46 27 May 2026 $29.55 28 May 2026 $29.78 29 May 2026 $29.31 1 Jun 2026 $29.76 2 Jun 2026 $27.34 3 Jun 2026 $28.34 4 Jun 2026 $30.10 5 Jun 2026 $28.01 8 Jun 2026 $29.46 9 Jun 2026 $29.27 10 Jun 2026 $27.80 11 Jun 2026 $30.35 12 Jun 2026 $27.75 15 Jun 2026 $27.96 16 Jun 2026 $27.16 17 Jun 2026 $29.21 18 Jun 2026 $28.82 22 Jun 2026 $29.79 23 Jun 2026 $28.64 24 Jun 2026 $30.65 25 Jun 2026 $31.96 26 Jun 2026 $33.28 29 Jun 2026 $34.30 30 Jun 2026 $35.84 1 Jul 2026 $36.08 2 Jul 2026 $37.09 6 Jul 2026 $35.04 7 Jul 2026 $37.06 8 Jul 2026 $38.53 9 Jul 2026 $39.80 10 Jul 2026 $39.32 13 Jul 2026 $36.57 14 Jul 2026 $37.91 15 Jul 2026 $37.33 16 Jul 2026 $37.22 17 Jul 2026 $37.87 20 Jul 2026 $35.99 21 Jul 2026 $37.44 22 Jul 2026 $35.31 23 Jul 2026 $35.23 24 Jul 2026 $36.56 27 Jul 2026 $9.91 28 Jul 2026 $12.31 29 Jul 2026 $15.02 30 Jul 2026 $14.03 31 Jul 2026 $13.02 3 Aug 2026 $12.55 4 Aug 2026 $12.94 5 Aug 2026 $12.92 6 Aug 2026 $13.28 7 Aug 2026 $12.17 10 Aug 2026 $12.18 11 Aug 2026 $11.98 12 Aug 2026 $11.38 13 Aug 2026 $11.58 14 Aug 2026 $11.75 17 Aug 2026 $11.25 18 Aug 2026 $11.82 19 Aug 2026 $12.15 20 Aug 2026 $11.23 21 Aug 2026 $11.21 24 Aug 2026 $11.36 25 Aug 2026 $12.54 26 Aug 2026 $12.86 27 Aug 2026 $12.54 28 Aug 2026 $12.60 31 Aug 2026 $12.97 1 Sep 2026 $13.31 2 Sep 2026 $13.06 3 Sep 2026 $13.14 4 Sep 2026 $13.77 8 Sep 2026 $13.95 9 Sep 2026 $13.71 10 Sep 2026 $13.79 11 Sep 2026 $13.00 14 Sep 2026 $13.15 15 Sep 2026 $12.08 16 Sep 2026 $11.40 17 Sep 2026 $11.32 18 Sep 2026 $10.92 21 Sep 2026 $10.90 22 Sep 2026 $10.86 23 Sep 2026 $10.77 24 Sep 2026 $10.76 25 Sep 2026 $10.46 28 Sep 2026 $10.45 29 Sep 2026 $10.15 30 Sep 2026 $10.19 1 Oct 2026 $9.63 2 Oct 2026 $9.82 5 Oct 2026 $9.28 6 Oct 2026 $9.69 7 Oct 2026 $9.36 8 Oct 2026 $9.15 9 Oct 2026 $8.83 Novo Holdings A/S 10% owner Bought $16.20M 28 Oct 2025 · at $17.00 · 34.9% of stake Catalyst4, Inc. 10% owner Bought $92.50M 28 Oct 2025 · at $17.00 · 38.2% of stake Malenka Robert C. Director Sold at will $121.70K 28 Jan 2026 · at $18.65 · 1.6% of stake Malenka Robert C. Director Sold at will $394.41K 29 Jan 2026 · at $18.55 · 5.4% of stake Malenka Robert C. Director Sold at will $119.74K 30 Jan 2026 · at $18.11 · 1.8% of stake Malenka Robert C. Director Sold at will $126.84K 2 Feb 2026 · at $18.02 · 1.9% of stake Malenka Robert C. Director Sold at will $18.00 3 Feb 2026 · at $18.00 · 0.0% of stake Malenka Robert C. Director Sold at will $119.99K 10 Feb 2026 · at $18.12 · 1.8% of stake Garnett Timothy John Director Bought $252.68K 10 Feb 2026 · at $17.89 Malenka Robert C. Director Sold at will $4.34K 11 Feb 2026 · at $18.00 · 0.1% of stake Malenka Robert C. Director Sold at will $220.63K 13 Feb 2026 · at $18.21 · 3.4% of stake Pavlov George Director Bought $186.30K 18 Feb 2026 · at $17.48 Pavlov George Director Bought $77.69K 19 Feb 2026 · at $17.57 · 41.5% of stake Malenka Robert C. Director Sold at will $39.58K 20 Feb 2026 · at $18.03 · 0.6% of stake Pavlov George Director Bought $177.17K 20 Feb 2026 · at $17.86 · 65.8% of stake Malenka Robert C. Director Sold at will $207.46K 23 Feb 2026 · at $18.42 · 3.3% of stake Malenka Robert C. Director Sold at will $13.36K 24 Feb 2026 · at $18.15 · 0.2% of stake Hanson Kristopher General Counsel Sold at will $40.98K 15 Apr 2026 · at $26.80 · 0.8% of stake Lillie James Woodruff Chief Scientific Officer Sold at will $46.40K 15 Apr 2026 · at $26.82 · 0.6% of stake Foff Erin Pennock Chief Medical Officer Sold at will $54.86K 15 Apr 2026 · at $26.84 · 0.5% of stake Setia Vishwas Chief Financial Officer Sold at will $75.40K 15 Apr 2026 · at $26.87 · 0.7% of stake Kreitzer Anatol Chief Discovery Officer Sold at will $88.24K 15 Apr 2026 · at $26.61 · 1.3% of stake GILLIS JONATHAN CAAO and PAO Sold at will $95.53K 15 Apr 2026 · at $26.61 · 1.4% of stake Malenka Robert C. Director Sold on a plan $231.15K 15 Apr 2026 · at $26.90 · 2.6% of stake Kroeger Christopher A. Chief Executive Officer Sold at will $246.01K 15 Apr 2026 · at $26.93 · 0.6% of stake Setia Vishwas Chief Financial Officer Sold at will $3.17K 16 Apr 2026 · at $27.37 · 0.0% of stake Hanson Kristopher General Counsel Sold at will $8.16K 16 Apr 2026 · at $27.37 · 0.2% of stake Foff Erin Pennock Chief Medical Officer Sold at will $32.00K 16 Apr 2026 · at $27.37 · 0.3% of stake Lillie James Woodruff Chief Scientific Officer Sold at will $76.18K 16 Apr 2026 · at $27.37 · 0.9% of stake Kroeger Christopher A. Chief Executive Officer Sold at will $275.14K 16 Apr 2026 · at $27.37 · 0.6% of stake Kreitzer Anatol Chief Discovery Officer Sold on a plan $1.35M 27 Apr 2026 · at $29.66 · 17.7% of stake GILLIS JONATHAN CAAO and PAO Sold on a plan $1.54M 27 Apr 2026 · at $29.74 · 20.7% of stake GILLIS JONATHAN CAAO and PAO Sold on a plan $544.32K 28 Apr 2026 · at $30.35 · 9.0% of stake Hanson Kristopher General Counsel Sold on a plan $388.18K 4 May 2026 · at $27.89 · 7.3% of stake Setia Vishwas Chief Financial Officer Sold on a plan $418.93K 4 May 2026 · at $28.11 · 3.8% of stake Kroeger Christopher A. Chief Executive Officer Sold on a plan $435.36K 4 May 2026 · at $27.96 · 1.0% of stake Foff Erin Pennock Chief Medical Officer Sold on a plan $437.63K 4 May 2026 · at $27.96 · 3.9% of stake Lillie James Woodruff Chief Scientific Officer Sold on a plan $441.81K 4 May 2026 · at $27.96 · 5.4% of stake Kroeger Christopher A. Chief Executive Officer Sold on a plan $295.29K 5 May 2026 · at $28.20 · 0.6% of stake Foff Erin Pennock Chief Medical Officer Sold on a plan $298.22K 5 May 2026 · at $28.20 · 2.7% of stake Setia Vishwas Chief Financial Officer Sold on a plan $307.44K 5 May 2026 · at $28.20 · 2.9% of stake Lillie James Woodruff Chief Scientific Officer Sold on a plan $312.84K 5 May 2026 · at $28.20 · 4.0% of stake Setia Vishwas Chief Financial Officer Sold on a plan $298.34K 6 May 2026 · at $28.24 · 2.9% of stake Kroeger Christopher A. Chief Executive Officer Sold on a plan $681.58K 6 May 2026 · at $28.76 · 1.5% of stake Foff Erin Pennock Chief Medical Officer Sold on a plan $691.75K 6 May 2026 · at $28.76 · 6.4% of stake Lillie James Woodruff Chief Scientific Officer Sold on a plan $713.60K 6 May 2026 · at $28.76 · 9.2% of stake Lillie James Woodruff Chief Scientific Officer Sold on a plan $20.39K 7 May 2026 · at $28.28 · 0.3% of stake Foff Erin Pennock Chief Medical Officer Sold on a plan $126.64K 7 May 2026 · at $28.54 · 1.3% of stake Kroeger Christopher A. Chief Executive Officer Sold on a plan $575.80K 7 May 2026 · at $28.65 · 1.3% of stake Kroeger Christopher A. Chief Executive Officer Sold on a plan $952.84K 8 May 2026 · at $27.69 · 2.2% of stake Hanson Kristopher General Counsel Sold on a plan $419.26K 11 May 2026 · at $30.13 · 7.9% of stake Kroeger Christopher A. Chief Executive Officer Sold on a plan $421.00K 11 May 2026 · at $30.11 · 0.9% of stake Kroeger Christopher A. Chief Executive Officer Sold on a plan $3.21M 18 May 2026 · at $27.19 · 7.8% of stake Hanson Kristopher General Counsel Sold at will $266.43K 15 Jul 2026 · at $36.70 · 4.5% of stake Lillie James Woodruff Chief Scientific Officer Sold at will $280.51K 15 Jul 2026 · at $36.70 · 3.1% of stake Kreitzer Anatol Chief Discovery Officer Sold on a plan $366.94K 15 Jul 2026 · at $36.49 · 4.8% of stake GILLIS JONATHAN CAO and Interim CFO Sold on a plan $367.09K 15 Jul 2026 · at $36.51 · 5.5% of stake Foff Erin Pennock Chief Medical Officer Sold on a plan $1.04M 15 Jul 2026 · at $36.64 · 8.2% of stake Kroeger Christopher A. Chief Executive Officer Sold at will $2.27M 15 Jul 2026 · at $36.69 · 4.4% of stake Hanson Kristopher General Counsel Sold at will $298.62K 16 Jul 2026 · at $36.78 · 5.2% of stake GILLIS JONATHAN CAO and Interim CFO Sold on a plan $311.11K 16 Jul 2026 · at $36.80 · 4.9% of stake Lillie James Woodruff Chief Scientific Officer Sold at will $314.41K 16 Jul 2026 · at $36.79 · 3.6% of stake Kreitzer Anatol Chief Discovery Officer Sold on a plan $333.23K 16 Jul 2026 · at $36.80 · 4.5% of stake Foff Erin Pennock Chief Medical Officer Sold on a plan $553.33K 16 Jul 2026 · at $36.77 · 4.7% of stake Kroeger Christopher A. Chief Executive Officer Sold at will $2.54M 16 Jul 2026 · at $36.79 · 5.2% of stake Hanson Kristopher General Counsel Sold at will $42.83K 17 Jul 2026 · at $37.90 · 0.8% of stake Lillie James Woodruff Chief Scientific Officer Sold at will $78.72K 17 Jul 2026 · at $37.90 · 0.9% of stake Foff Erin Pennock Chief Medical Officer Sold on a plan $138.56K 17 Jul 2026 · at $37.90 · 1.2% of stake Kroeger Christopher A. Chief Executive Officer Sold at will $635.92K 17 Jul 2026 · at $37.90 · 1.3% of stake Kreitzer Anatol Chief Discovery Officer Sold on a plan $645.72K 17 Jul 2026 · at $37.60 · 8.9% of stake GILLIS JONATHAN CAO and Interim CFO Sold on a plan $694.46K 17 Jul 2026 · at $37.60 · 11.4% of stake Cox Troy Director Bought $148.70K 28 Jul 2026 · at $9.52 Catalyst4, Inc. 10% owner Bought $2.28M 28 Jul 2026 · at $11.04 · 1.0% of stake Catalyst4, Inc. 10% owner Bought $37.89K 29 Jul 2026 · at $12.63 · 0.0% of stake Catalyst4, Inc. 10% owner Bought $13.00M 30 Jul 2026 · at $13.00 · 5.0% of stake Lillie James Woodruff Chief Scientific Officer Sold on a plan $276.91K 3 Aug 2026 · at $12.54 · 9.8% of stake Catalyst4, Inc. 10% owner Bought $50.07M 14 Aug 2026 · at $11.38 · 21.0% of stake Hanson Kristopher General Counsel Sold on a plan $192.66K 16 Sep 2026 · at $11.67 · 10.8% of stake
11 buys32 sales at will35 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Net income
$161.15M
Free cash flow
$138.61M
Return on equity
-35.2%
Return on capital
-29.1%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
0K -78M FY24 Fiscal year 2024 Revenue $0.00 Net income $77.58M Margin n/a 0K -161M FY25 Fiscal year 2025 Revenue $0.00 Net income $161.15M Margin n/a
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
16 Sep 2026 Hanson Kristopher
General Counsel
 Sold on a plan $192.66K 10.8%
14 Aug 2026 Catalyst4, Inc.
10% owner
 Bought $50.07M 21.0%
3 Aug 2026 Lillie James Woodruff
Chief Scientific Officer
 Sold on a plan $276.91K 9.8%
30 Jul 2026 Catalyst4, Inc.
10% owner
 Bought $13.00M 5.0%
29 Jul 2026 Catalyst4, Inc.
10% owner
 Bought $37.89K 0.0%
28 Jul 2026 Catalyst4, Inc.
10% owner
 Bought $2.28M 1.0%